We are live on ! Find out more
HP

Harbourvest Partners Portfolio holdings

AUM $101M
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+17.19%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$256M
AUM Growth
-$14.3M
Cap. Flow
-$6.57M
Cap. Flow %
-2.57%
Top 10 Hldgs %
95.13%
Holding
40
New
5
Increased
–
Reduced
3
Closed
14

Top Buys

Rank Stock Value
1
SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
+$25.9M
2
MCRB icon
Seres Therapeutics
MCRB
+$2.46M
3
WORK
Slack Technologies, Inc.
WORK
+$2.06M
4
ADVM
Adverum Biotechnologies
ADVM
+$1.66M
5
RAPT
RAPT Therapeutics
RAPT
+$336K

Top Sells

Rank Stock Value
1
ONEM
1Life Healthcare
ONEM
+$9.97M
2
SWI
SolarWinds Corporation Common Stock
SWI
+$9M
3
PS
Pluralsight, Inc. Class A Common Stock
PS
+$3.03M
4
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$2.5M
5
NTNX icon
Nutanix
NTNX
+$2.35M

Sector Composition

Rank Sector Weight
1 Healthcare 50.29%
2 Technology 46.24%
3 Financials 2.12%
4 Consumer Discretionary 1.04%
5 Energy 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SWI
1
DELISTED
SolarWinds Corporation Common Stock
SWI
$111M 43.46%
7,052,362
-411,053
-6% -$9M
EVLO
2
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$37M 14.47%
153,175
– –
SGTX
3
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$35.6M 13.9%
+56,980
New +$25.9M
KLDO
4
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$16.7M 6.52%
1,833,832
-86,195
-4% -$707K
AXLA
5
DELISTED
Axcella Health Inc. Common Stock
AXLA
$14.6M 5.69%
112,319
– –
TDOC icon
6
Teladoc Health
TDOC
$1.69B
$10.2M 3.98%
50,943
– –
RUBY
7
DELISTED
Rubius Therapeutics, Inc
RUBY
$7.49M 2.93%
986,878
– –
HAPN
8
Happen Inc
HAPN
$2.19B
$5.42M 2.12%
513,440
– –
LOV
9
DELISTED
Spark Networks SE American Depositary Shares
LOV
$2.67M 1.04%
502,576
– –
WORK
10
DELISTED
Slack Technologies, Inc.
WORK
$2.58M 1.01%
+61,037
New +$2.06M
ZUO
11
DELISTED
Zuora, Inc.
ZUO
$2.28M 0.89%
163,894
– –
MCRB icon
12
Seres Therapeutics
MCRB
$46.5M
$2.06M 0.8%
+4,195
New +$2.46M
YEXT icon
13
Yext
YEXT
$564M
$1.81M 0.71%
115,147
– –
ADVM
14
DELISTED
Adverum Biotechnologies
ADVM
$1.45M 0.57%
+13,415
New +$1.66M
PGNY icon
15
Progyny
PGNY
$2.41B
$1.26M 0.49%
29,743
-57,831
-66% -$1.88M
AR icon
16
Antero Resources
AR
$10.5B
$719K 0.28%
131,895
– –
CTMX icon
17
CytomX Therapeutics
CTMX
$701M
$519K 0.2%
79,193
– –
TRVN
18
DELISTED
Trevena, Inc.
TRVN
$500K 0.2%
374
– –
CSLT
19
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$454K 0.18%
349,070
– –
KA
20
DELISTED
Kineta, Inc. Common Stock
KA
$375K 0.15%
3,147
– –
XGN icon
21
Exagen
XGN
$108M
$343K 0.13%
25,982
– –
EPZM
22
DELISTED
Epizyme, Inc
EPZM
$268K 0.1%
24,686
– –
RAPT
23
DELISTED
RAPT Therapeutics
RAPT
$244K 0.1%
+1,544
New +$336K
NXTC icon
24
NextCure
NXTC
$22.1M
$109K 0.04%
837
– –
METC icon
25
Ramaco Resources Class A
METC
$637M
$43K 0.02%
15,453
– –
1
2

Similar funds

VCM
Vines Capital Management Monroe, Louisiana $101M AUM
TCI
Triveni Capital Investments Stamford, Connecticut $101M AUM
RPC
Royal Palms Capital Whitefish, Montana $101M AUM
XC
XY Capital Central, Hong Kong $101M AUM 1.14% 1-Year Est. Return
AWA
Ark Wealth Advisors Yorba Linda, California $101M AUM
HWM
Hobbs Wealth Management Zionsville, Indiana $101M AUM 22.3% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
ROP
Rule One Partners Moreland, Georgia $101M AUM 6.3% 1-Year Est. Return

Harbourvest Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Harbourvest Partners held 40 positions worth $256M, down 5.3% from $270M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Harbourvest Partners's Q4 2020 filing shows 5 new, 3 reduced and 14 closed positions. Its largest new stake was Sigilon Therapeutics, Inc. Common Stock: 56,980 shares worth $35.6M. The largest sale was 1Life Healthcare, an estimated $9.97M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Harbourvest Partners's largest Q4 2020 buy was Sigilon Therapeutics, Inc. Common Stock: 56,980 shares worth $35.6M.
  • Harbourvest Partners's biggest Q4 2020 reduction was SolarWinds Corporation Common Stock, cutting an estimated $9M.
  • Harbourvest Partners fully exited 1Life Healthcare in Q4 2020, selling an estimated $9.97M.
  • Harbourvest Partners's ten largest holdings make up 95% of its $256M portfolio in Q4 2020.
  • Harbourvest Partners opened 5 new positions and closed 14 in Q4 2020.
  • Harbourvest Partners's portfolio value fell 5.3% quarter-over-quarter to $256M.

Based on Harbourvest Partners's 13F filing for Q4 2020, filed 16 Feb 2021.